Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 14 citing Peters: Antipermeability and antiproliferative effects of standard and frozen bevacizumab.... (0.09 sec) 

Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in …


E Yoeruek, F Ziemssen, S Henke-Fahle, O Tatar … - Acta Ophthalmologica, 2008 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 20 - Related articles - BL Direct - All 2 versions

VEGF-induced effects on proliferation, migration and tight junctions are restored by …

- prsjournal.com
H Deissler, S Lang, GE Lang - British Medical Journal, 2008 - bjo.bmj.com
Results: While both isoforms stimulated proliferation of iBREC, only VEGF 165
influenced cell migration. The addition of ranibizumab counteracted this
stimulation without inhibition of the basal levels of migration and ...
Cited by 6 - Related articles - BL Direct - All 7 versions

Inhibitory effects of bevacizumab on angiogenesis and corneal neovascularization


YS Han, JE Lee, JW Jung, JS Lee - Graefe's Archive for Clinical and Experimental …, 2009 - Springer
Abstract Background To evaluate the inhibitory effects of bevaci- zumab
(Avastin®) on angiogenesis using cultured human umbilical vein endothelial
cells (HUVECs) in vitro and on corneal neovascularization by ...
Cited by 3 - Related articles - All 2 versions

Off-Label Use of Bevacizumab for the Treatment of Age-Related Macular Degeneration: …

- prsjournal.com
F Ziemssen, S Grisanti, KU Bartz-Schmidt, MS … - Drugs &# 38; Aging, 2009 - ingentaconnect.com
Abstract. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . 295 1. Approved Indications of Bevacizumab. . . . . . . . . . . . ...
Cited by 1 - Related articles - All 7 versions

Clinical and histological findings after intravitreal injection of bevacizumab (Avastin®) in a …


N Lassota, JU Prause, E Scherfig, JF Kiilgaard … - Acta Ophthalmologica, 2009 - interscience.wiley.com
Methods: Choroidal neovascularization was induced surgically in 11 porcine eyes
by perforating Bruch's membrane with a retinal perforator. After closure of the
ports used for the vitrectomy, which was performed to facilitate the ...
Cited by 1 - Related articles - All 2 versions

Bevacizumab (Avastin) 对眼科疾病的治疗作用


宋徽, 任兵, 高晓唯 - 国际眼科杂志, 2008 - cqvip.com
首页; 期刊导航; 知识社区; 学者空间; 学术机构; 专题导读;
充值中心; 论文翻译. 登录 注册 帮助. 维普资讯 ...
Cited by 1 - Related articles - All 3 versions

Verteporfin Combination Regimens in the Treatment of Neovascular Age-Related Macular …

- duanessolution.com
GK SHAH, DN SANG, MS HUGHES - Retina, 2009 - journals.lww.com
From the *Barnes Retina Institute, Washington University School of Medicine, St.
Louis, Missouri; and †Department of Ophthalmology, Ophthalmic Consultants of
Boston, Schepens Eye Research Institute, Harvard Medical School, Boston, ...
Related articles - All 8 versions

Clinical and Histological Aspects of CNV Formation: Studies in an Animal Model


N Lassota - Acta Ophthalmologica, 2008 - interscience.wiley.com
The purpose of the present thesis was to develop an animal model of CNV in order
to study the early formation of CNV and to test the effects of an
anti-angiogenic treatment. Porcine eyes were chosen as a substrate for CNV ...
Related articles - All 2 versions

Laboratory science-Extended reports: EXTENDED REPORT Antipermeability and …


BJ Ophthalmol - bjo.bmj.com
We read the paper titled “Anti-permeability and anti-proliferative effects of
standard and frozen bevacizumab on choroidal endothelial cells” by Peters et
al [1] in Br J Ophthalmol. Dec. 2006 issue with great interest. There are a ...
Related articles - All 2 versions

Bevacizumab Sterility in Multiple Doses from a Single-Use Vial


K Ornek, ZC Karahan, A Ergin, A Tekeli, O … - The annals of pharmacotherapy, 2008 - Harvey Whitney Books
METHODS: Four groups of vials were used to simulate the storage and use
conditions for bevacizumab. Each group contained 11 doses of 0.2 mL of
bevacizumab. One sample from each group was cultured once each day at 37 ...
Related articles - All 5 versions


Result Page: 

1

2

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google